Amarin Corp Plc (AMRN)

[DeepBreath]

Exactly. There is more to this than is Vascepa effective for lowering CVE's. The failed studies include drugs that are still prescribed yet the FDA wants to challenge the efficacy of Vascepa, when the only EPA study, Jelis, confirms the efficacy of this drug.

Risk/Reward favors approving Vascepa now. The money patients spend on Vascepa will probably be spent on a proven non-effective drug anyways. Then they can deal with the severe side effects nutsy conveniently ignores.

If Vascepa's efficacy is proven with REDUCE-IT, then the FDA will be responsible for the many lives lost. Especially considering the public outcry recently, that is a position I would not want to be in.